Clinical Trial

Cumulus Cell Mitochondrial Activity as a Non-invasive Marker of Embryo Quality (FLIM)

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 18, 2026 (before its estimated May 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study aims to test the extent of association of FLIM parameters of cumulus cells with clinical outcomes (clinical pregnancy, ongoing pregnancy at 12 weeks, and live birth) of the embryos that result from the enclosed oocytes.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2022-04-10; most recent amendment 2026-03-17.
Status change: Recruiting → Active, Not Recruiting 2025-05-06
Status change: Not Yet Recruiting → Recruiting 2022-05-31
Trial Details
NCT Number NCT05332769
Lead Sponsor Mỹ Đức Hospital
Collaborators: The Needleman Lab, Northwest Lab Building 359,52 Oxford Street Cambridge MA 02138., Harvard University Faculty of Medicine, Hospital Foch, Suresnes, France.
Conditions IVF/ICSI, Frozen Embryo Transfer, Cumulus Cell, Fluorescence Lifetime Imaging Microscopy
Enrollment 200 participants
Start Date 2022-04-25
Primary Completion 2026-05-30 (estimated)
Study Completion 2026-12-30 (estimated)
Updated on ClinicalTrials.gov 2026-03-18